Topical Bioadhesives Market Overview
According to the latest research by Future Market Insights, Topical Bioadhesives Market is set to experience growth during the year 2021-2031. The demand for topical bioadhesives increasing due to vast applications in various industries segments.
Another major business facilitator of the bioadhesive market is the global trend towards bioadhesive materials and reducing the use of synthetic adhesives.
Commercial product episil® is based on FluidCrystal® topical bioadhesive technology. A growing population and growing awareness of the benefits of bio-based products are driving the demand for health care products and services significantly.
Adhesives are included in the formulation of medical products used in drug delivery systems, thereby enabling absorption of the drug into biological components. Bioadhesives are suitable for use in biomedical applications, including skin or body tissues. Increase in usage of topical bioadhesives due to increasing its scope in variety of industries is the major growth driver of topical bioadhesive market.
What Is Driving Demand For Topical Bioadhesives?
Bioadhesive-based oral delivery systems have facilitated numerous studies with limited success. Different types of trans mucosal oral systems have been navigated using different bioadhesive polymers. Many of these systems are based on hydrophilic hydrogel polymers and are designed primarily for buccal or sublingual applications.
Bioadhesives are generally as capable as synthetic adhesives, but their biggest drawback is that they have a limited shelf life. Especially in healthcare, there is a growing demand for products long in internal organizations from the need to reduce operating costs. Also, the life requirements of each sector are different. Therefore, research projects should focus on blending polymers to create the most capable products.
Biodhesives are increasingly gaining more popularity in diverse areas of clinical applications, including wound closure and healing, drug delivery, implantation of medical devices, tissue engineering and dental and bone applications.
Europe is the largest region in terms of volume and value, followed by North America and Asia Pacific. As expected, Asia Pacific is to achieve the highest CAGR over the next 5 -10 years. New advancements in the field enhancing many key players to develop new technologies. Increasing mergers and acquisitions has propelled the growth of market.
Increasing Incidence Of Surgeries And Accidental Cases Likely To Augment Topical Bioadhesives Sales
1.16 million Caesarean sections performed in the Europe in 2018. Hip replacements were performed 311 times per 100 000 peoples in Germany in 2018 and between 275 and 300 times per 100 000 people in Austria, Belgium and Finland; these were the highest frequencies among the EU Member States for which data are available.
Bioadhesives most prominently used in surgeries as a replacement for surgical sutures and haemostasis and for drug delivery system. Increasing surgeries will boost the growth of topical bioadhesives sales.
U.S. And Canada Topical Bioadhesives Market Outlook
In 2015, North American bioadhesives market was $216 MM (~6% of the total $3.6B), with a CAGR 3% during 2015-2019. Drivers increasing consumptions of bioadhesives are growing packaging & paper industry, construction industry, personal care, and medical applications.
Bioadhesives have gained commercial interest because they are generally biocompatible, they can be used in biomedical applications involving skin or other body tissues. Some work in wet and underwater environments, while others can adhere to low surface energy substrates.
Closure Medical Corp. introduces the innovative ProPen and ProPen XL, a new single-use delivery system for use with high-viscosity DERMABOND Topical Skin Adhesive. Johnson & Johnson Medical N.V has acquired Closure Medical Corp in 2005.
Europe Demand Outlook For Topical Bioadhesives
Increasing cases of surgeries and accidental cases has boost the expected growth of the market. Advanced Medical Solutions Group plc in 2019 acquired French company Biomatlante SA, international developer and manufacturer of surgical biomaterial.
FluidCrystal® (Camurus AB) topical bioadhesive is a liquid product that forms a bioadhesive film when applied to body tissues. The film functions as an invisible patch and slowly and precisely releases the active ingredient for treatment systemically or locally.
Formulation is applied topically as a low-viscosity liquid. After that, it diffuses and absorbs trace amounts of water and changes into a thin bioadhesive liquid crystal film.
Who Are The Key Manufacturers And Suppliers Of Topical Bioadhesives?
Some of the key players operating in the Topical Bioadhesives Market are
- Ellsworth Adhesives
- Henkel Adhesives Technologies India Private Limited
- The Lubrizol Corporation
- Camurus AB
- Ethicon US
- Advanced Medical Solutions Group plc
- B. Braun Melsungen AG
- VYGON (UK) LTD
Advanced Medical Solutions announced acquisition of Raleigh Adhesive Coatings, wound care and bio-diagnostics coatings business in 2020.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
By Time of Application:
- Short Term Application
- Long Term Application
By Material Type:
- natural gum
By End Users:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
- Personal Care Industry
- Pulp and paper Industry
- North America
- Latin America
- South Asia
- East Asia
- The Middle East and Africa